Literature DB >> 28408269

Chlorajaponols A-F, sesquiterpenoids from Chloranthus japonicus and their in vitro anti-inflammatory and anti-tumor activities.

Zhi-Guo Zhuo1, Guo-Zhen Wu1, Xin Fang1, Xin-Hui Tian1, Hong-Yuan Dong1, Xi-Ke Xu1, Hui-Liang Li1, Ning Xie2, Wei-Dong Zhang3, Yun-Heng Shen4.   

Abstract

Two new eudesmane sesquiterpenoids, chlorajaponols A-B (1-2), two new guaiane sesquiterpenoids, chlorajaponols C-D (3-4), a new germacrane sesquiterpenoid, chlorajaponol E (5), and a new lindenane sesquiterpenoid, chlorajaponol F (6), along with 8 known sesquiterpenoids and 6 known disesquiterpenoids, were isolated from the whole plant of Chloranthus japonicus. Their structures were established by extensive analysis of NMR spectroscopic data in combination with mass spectrometry. The structures of compounds 1-4 were confirmed by single crystal X-ray diffraction (CuKα radiation). The possible biogenetic pathways of compounds 1-6 were discussed. Chlorajaponol B (2) showed significant inhibition against nitric oxide (NO) release in LPS-induced RAW264.7 macrophages with the IC50 value of 9.56±0.71μM, comparable to that of positive control amino guanidine (8.50±0.35μM). Shizukaol C (18) strongly suppressed the proliferation of three human tumor cell lines MGC803, HepG2, and HL-60 with IC50 values of 4.60±1.05μM, 3.17±0.66μM, and 1.57±0.27μM, respectively.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chlorajaponols A–F; Chloranthus japonicus; Cytotoxicity; Nitric oxide; Sesquiterpenoid

Mesh:

Substances:

Year:  2017        PMID: 28408269     DOI: 10.1016/j.fitote.2017.04.009

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  1 in total

1.  Chemical Constituents of the Ethyl Acetate Extract from Diaphragma juglandis Fructus and Their Inhibitory Activity on Nitric Oxide Production In Vitro.

Authors:  Dan Wang; Yan Mu; Hongjing Dong; Huijiao Yan; Cui Hao; Xiao Wang; Lisi Zhang
Journal:  Molecules       Date:  2017-12-29       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.